Nichols & Pratt Advisers’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,505
Closed -$217K – 100
2024
Q4
$217K Buy
1,505
+150
+11% +$21.5K 0.01% 99
2024
Q3
$202K Sell
1,355
-1,200
-47% -$172K 0.01% 104
2024
Q2
$322K Hold
2,555
– – 0.02% 88
2024
Q1
$470K Hold
2,555
– – 0.03% 82
2023
Q4
$459K Buy
2,555
+190
+8% +$29.6K 0.03% 82
2023
Q3
$376K Buy
+2,365
New +$387K 0.03% 87

Other funds holding RGEN

Nichols & Pratt Advisers's RGEN Position: Q1 2025 in Review

Nichols & Pratt Advisers sold out of Repligen (RGEN) in Q1 2025, closing a stake of 1,505 shares — an estimated $217K sold.

Nichols & Pratt Advisers first reported a position in RGEN in Q3 2023 and held it in 6 quarters. The position peaked at $470K in Q1 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.

  • Nichols & Pratt Advisers reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
  • Nichols & Pratt Advisers sold 1,505 Repligen shares in Q1 2025, an estimated $217K.
  • Nichols & Pratt Advisers first reported a position in Repligen in Q3 2023 and held it in 6 quarters.
  • Nichols & Pratt Advisers's Repligen position peaked at $470K in Q1 2024.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.

Based on Nichols & Pratt Advisers's 13F filing for Q1 2025, filed 29 Apr 2025.